Tamarack Advisers’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-110,000
Closed -$254K 39
2023
Q2
$254K Sell
110,000
-365,000
-77% -$1.03M 0.08% 32
2023
Q1
$1.21M Buy
475,000
+225,000
+90% +$645K 0.44% 29
2022
Q4
$628K Sell
250,000
-50,000
-17% -$140K 0.32% 32
2022
Q3
$870K Sell
300,000
-50,000
-14% -$210K 0.51% 34
2022
Q2
$1.58M Buy
350,000
+55,000
+19% +$327K 0.92% 26
2022
Q1
$2.25M Buy
295,000
+145,000
+97% +$1.28M 1.06% 27
2021
Q4
$1.75M Hold
150,000
0.72% 38
2021
Q3
$1.86M Buy
+150,000
New +$1.69M 0.59% 32

Other funds holding SLGC

Tamarack Advisers's SLGC Position: Q3 2023 in Review

Tamarack Advisers sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q3 2023, closing a stake of 110,000 shares — an estimated $254K sold.

Tamarack Advisers first reported a position in SLGC in Q3 2021 and held it in 8 quarters. The position peaked at $2.25M in Q1 2022. 118 funds tracked by Wall St. Rank hold SLGC as of Q3 2023.

  • Tamarack Advisers reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Tamarack Advisers sold 110,000 SomaLogic, Inc. Class A Common Stock shares in Q3 2023, an estimated $254K.
  • Tamarack Advisers first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 8 quarters.
  • Tamarack Advisers's SomaLogic, Inc. Class A Common Stock position peaked at $2.25M in Q1 2022.
  • 118 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q3 2023.

Based on Tamarack Advisers's 13F filing for Q3 2023, filed 16 Nov 2023.